Fulcrum Therapeutics initial beneficial ownership filing shows Kevin Tang as 10% owner
FULC•Form 3 filing shows 10% ownership
Fulcrum Therapeutics Form 3 filed for Kevin Tang and Tang Capital Management, listed as 10% owners.
Disclosure shows indirect beneficial ownership of 6,663,383 shares of common stock.
Event date: July 13, 2026; filing signed July 15, 2026.
